LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-12 Cr | ₹-9.49 Cr | ₹7.35 Cr | ₹-6.17 Cr | ₹-0.16 Cr |
What is the latest Cash Flow from Investing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-12 Cr |
| Mar2024 | ₹-9.49 Cr |
| Mar2023 | ₹7.35 Cr |
| Mar2022 | ₹-6.17 Cr |
| Mar2021 | ₹-0.16 Cr |
How is Cash Flow from Investing Activities of LYKA LABS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-12 Cr | Negative | |
| Mar2024 | ₹-9.49 Cr | Negative | |
| Mar2023 | ₹7.35 Cr | Positive | |
| Mar2022 | ₹-6.17 Cr | Negative | |
| Mar2021 | ₹-0.16 Cr | - | |
Compare Cash Flow from Investing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹207.8 Cr | -5.7% | -1.3% | -51.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -5.7% |
-1.3% |
-51.5% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses